Correction: Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK

Ruigómez A, Vora P, Balabanova Y, et al. Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK. BMJ Open 2019;9:e031342. doi: 10.1136/bmjopen-2019-031342.

This article was previously published with an error.

In table 1, the mean age of patients in the Rivaroxaban column should read 74.3 (10.5) and not 71.7 (14.4).